MedStar Authors catalog › Details for: Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer. [Review]
Normal view MARC view ISBD view

Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer. [Review]

by Van Nostrand, Douglas.
Citation: Endocrinology & Metabolism Clinics of North America. 46(3):783-793, 2017 Sep.Journal: Endocrinology and metabolism clinics of North America.Published: 2017ISSN: 0889-8529.Full author list: Van Nostrand D.UI/PMID: 28760238.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Washington Hospital CenterDepartment(s): Medicine/Nuclear MedicineActivity type: Journal Article.Medline article type(s): Journal Article | ReviewOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.ecl.2017.04.007 (Click here) Abbreviated citation: Endocrinol Metab Clin North Am. 46(3):783-793, 2017 Sep.Local Holdings: Available online from MWHC library: 1996 - present.Abstract: This article discusses the more controversial areas of the management of differentiated thyroid cancer, namely, the utility of pretherapy staging radioiodine scans; the prescribed activity for iodine-131 remnant ablation, adjuvant treatment, and distant metastases; preparation with thyroid hormone withdrawal versus recombinant human thyroid-stimulating hormone; and the classification of radioiodine refractory differentiated thyroid cancer. The author reviews various aspects of the controversies, such as the recommendations of the 2015 guidelines of the American Thyroid Association, arguments for and against the various controversies, and selected references.Abstract: Copyright (c) 2017 Elsevier Inc. All rights reserved.

Powered by Koha